Chronic graft versus host disease (GVHD) is a major cause of morbidity and mortality after
allogeneic hematopoietic cell transplantation. Clinically, chronic GVHD is a pleiotropic …

Chronic graft-versus-host disease (GVHD) is a frequent and potentially life-threatening
complication of allogeneic hematopoietic stem cell transplantation. Increased …

Abstract The 2005 National Institutes of Health (NIH) Consensus Conference proposed new
criteria for diagnosing and scoring the severity of chronic graft-versus-host disease (GVHD) …

The relationship between intestinal microbiota composition and acute graft-versus-host
disease (GVHD) after allogeneic blood/marrow transplantation (allo-BMT) is not well …

Chronic graft-versus-host disease (GVHD) remains a common and potentially life-
threatening complication of allogeneic hematopoietic stem cell transplantation (HCT). The 2 …

Risk factors for grades 2-4 acute graft-versus-host disease (GVHD) and for chronic GVHD as
defined by National Institutes of Health consensus criteria were evaluated and compared in …

Identification of the immunomodulatory and regenerative properties of mesenchymal stem
cells (MSCs) have made them an attractive alternative therapeutic option for diseases with …

Chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell
transplantation is still associated with significant morbidity and mortality. First-line treatment …

Abstract In 2005, the National Institutes of Health Consensus Development Project on
Criteria for Clinical Trials in Chronic GVHD proposed a new scoring system for individual …

Several distinct graft-versus-host disease (GVHD)-related syndromes have been defined by
the National Institutes of Health Consensus Conference. We enrolled a prospective cohort of …